RICHTERS-SYNDROME SHOWING PRONOUNCED LYMPHADENOPATHY IN RESPONSE TO ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR

被引:9
作者
KAWACHI, Y
OZAKI, S
SAKAMOTO, Y
UCHIDA, T
MORI, M
SETSU, K
TANI, K
ASANO, S
机构
[1] Department of Internal Medicine, Takamatsu Red Cross Hospital, Kagawa
[2] First Department of Pathology, Okayama University Medical School, Okayama
[3] Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo
[4] Department of Hematology and Oncology, Institute of Medical Science and Fourth, Tokyo
[5] Department of Internal Medicine, University of Tokyo, Tokyo
关键词
RICHTERS SYNDROME; CLL; MALIGNANT LYMPHOMA; G-CSF; G-CSF RECEPTOR;
D O I
10.3109/10428199409049642
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A patient with Richter's syndrome developed rapid generalized lymph node enlargement with a decrease of peripheral blood lymphocytes after recombinant human granulocyte colony-stimulating factor (rhG-CSF) therapy for neutropenia induced by chemotherapy. The lymphadenopathy subsided spontaneously following discontinuation of rhG-CSF medication. Reinstitution of rhG-CSF therapy was followed by the same response as during initial therapy. Histopathologically, the lesions were characteristic of diffuse large cell lymphoma (DLL) with no evidence of myeloid cell involvement. No spontaneous contraction of enlarged lymph nodes followed withdrawal of the second course, but the enlargement subsided with chemotherapy. The patient died of myocardial infarction. All residual tumors examined post mortem presented microscopic features of small lymphocytic lymphoma (SLL), and G-CSF receptor was demonstrated on these neoplastic cells by Northern blot hybridization analysis. This observation indicates that some B cell malignancies may retain G-CSF receptor and respond to G-CSF.
引用
收藏
页码:509 / 514
页数:6
相关论文
共 27 条
[11]  
Gabrilove J.L., Jakubowski A., Scher H., Sternberg C., Wong G., Grous J., Yagoda A., Fain K., Moore M.A.S., Clarkson B., Oettgen H.F., Alton K., Welte K., Souza L., Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium, N. Engl. J. Med., 318, pp. 1414-1422, (1988)
[12]  
Touw I., Groot-Loonen J., Breeders L., Agthoven T.V., Hahlen K., Hagemeijer A., Ldwenberg B., Recombinant hematopoietic growth factors fail to induce a proliferative response in precursor B acute lymphoblastic leukemia, Leukemia, 3, pp. 356-362, (1989)
[13]  
Ode D.L., Zhou M., Findley H.W., Abdel-Mageed A., Ragab A.H., The effect of recombinant GM-CSF and G-CSF on the bone marrow cells of children with acute lymphoblastic leukemia, Leukemia, 6, pp. 1210-1212, (1992)
[14]  
Ogawa M., Masaoka T., Mizoguchi H., Takaku F., Nakashima M., A phase III study of KRN 8601 (rhG-CSF) on neutropenia induced by chemotherapy for malignant lymphoma, Japan. J. Cancer Chemother., 17, pp. 365-373, (1990)
[15]  
Oyama A., Ota K., Asano S., Takaku F., Miyazaki T., Uzuka Y., Omine M., Furusawa S., Hirashima K., Sanpi K., Takatani O., Sawada U., Nomura T., Toyama K., Aoki N., Mori M., Matsuda T., Saito H., Hirano M., Masaoka T., Kimura I., Dohi H., Toki H., Niho Y., To-Monaga M., Takatsuki K., Ogawa N., Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma, J. Japan. Soc. Cancer Ther., 25, pp. 1619-1634, (1990)
[16]  
Long J.C., Aisenberg A.C., Richter's syndrome. A terminal complication of chronic lymphocytic leukemia with distinct clinicopathologic features, Am. J. Clin. Pathol., 63, pp. 786-795, (1975)
[17]  
Foucar K., Rydell R.E., Richter's syndrome in chronic lymphocytic leukemia, Cancer, 46, pp. 118-134, (1980)
[18]  
Trump D.L., Mann R.B., Phelps R., Roberts H., Conley C.L., Richter's syndrome: Diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. A report of five cases and review of the literature, Am. J. Med., 68, pp. 539-548, (1980)
[19]  
Tsuchiya H., Watanabe M., Asou N., Kawano F., El-Sonbaty S.S., G-CSF receptors on the surface of Ph'-positive acute lymphoblastic leukemia (ALL) cells with myeloid surface antigens: ALL cells with myeloid antigens have myeloid function, Leukemia and Lymphoma, 6, pp. 497-501, (1992)
[20]  
Tsuchiya H., Asou N., Watanabe M., Shimosaka A., Takatsuki K., Matsuda I., Expression of the G-CSF receptor on the surface of lymphoblastic cells from patients with ALL with myeloid surface markers, N. Engl. J. Med., 325, pp. 1380-1381, (1991)